Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Cash from Investing Activities (2019 - 2024)

Addex Therapeutics' Cash from Investing Activities history spans 6 years, with the latest figure at -$5322.2 billion for Q4 2024.

  • On a quarterly basis, Cash from Investing Activities fell 83849.9% to -$5322.2 billion in Q4 2024 year-over-year; TTM through Dec 2024 was -$5321.9 billion, a 7390439.96% decrease, with the full-year FY2025 number at -$820996.0, down 115.48% from a year prior.
  • Cash from Investing Activities came in at -$5322.2 billion for Q4 2024, down from -$5.3 billion in the prior quarter.
  • The five-year high for Cash from Investing Activities was $6.4 billion in Q4 2023, with the low at -$5322.2 billion in Q4 2024.
  • Historically, Cash from Investing Activities has averaged -$355.2 billion across 5 years, with a median of -$3494.0 in 2021.
  • Biggest five-year swings in Cash from Investing Activities: surged 68023499414.92% in 2023 and later crashed 83849.9% in 2024.
  • Year by year, Cash from Investing Activities stood at -$53189.5 in 2020, then skyrocketed by 50.25% to -$26460.8 in 2021, then soared by 99.96% to -$9.34 in 2022, then skyrocketed by 68023499414.92% to $6.4 billion in 2023, then tumbled by 83849.9% to -$5322.2 billion in 2024.
  • Business Quant data shows Cash from Investing Activities for ADXN at -$5322.2 billion in Q4 2024, -$5.3 billion in Q3 2024, and $6.4 billion in Q4 2023.